H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.

Celebrate Valentine's Week while raising awareness for Congenital Heart Disease, highlighting challenges, triumphs, and the ...

Approximately 12 million people in India, about 1% of the population, live with epilepsy, with higher prevalence in rural ...

Depression and anxiety among patients with inflammatory arthritis is significantly undertreated, with large proportions not ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

Mental health is just as important as physical health, yet many people struggle to find the right treatment that meets their ...

While Steph, Una, and Big Zuu all skilfully dodged capture, it was Big Zuu who was ultimately crowned the victor by Bear in the Netflix show's inaugural season finale. If you're struggling and need to ...

Some three million Israelis experienced anxiety, depression and symptoms of post-traumatic stress disorder in the wake of the Oct. 7, 2023, Hamas-led massacre and subsequent war, State Comptroller ...

More than just a bedroom issue, ED can also be a sign of underlying health conditions that should not be ignored ...

Using psychedelic substances to treat PTSD, anxiety, and depression is not exactly a new idea. What is new however, are recent ...

Engelman faults Health Ministry for 'collapsed' health care system; Health Minister Uriel Buso set to double the scope of ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...